Pharmaceutical and Medical Device Industry of Republic of China (Taiwan)

1
CountryFocus Healthcare, Regulatory and
Reimbursement Landscape - Republic of China
(Taiwan)
Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.

• Published June 2014
• Single User PDF US 1995
• Corporate User PDF US 5985

2
CountryFocus Healthcare, Regulatory and
Reimbursement Landscape - Republic of China
(Taiwan)

• SummaryResearcher, the industry analysis
  specialist, has released its latest report,
  CountryFocus Healthcare, Regulatory and
  Reimbursement Landscape - Republic of China
  (Taiwan). The report is an essential source of
  information and analysis on the healthcare,
  regulatory and reimbursement landscape in the
  Republic of China (Taiwan).
• It identifies the key trends in the countrys
  healthcare market and provides insights into its
  demographic, regulatory, and reimbursement
  landscape and healthcare infrastructure. Most
  importantly, the report provides valuable
  insights into the trends and segmentation of its
  pharmaceutical and medical device markets.
• It is built using data and information sourced
  from proprietary databases, secondary research,
  and in-house analysis by Researchers team of
  industry experts.
•  

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
3
CountryFocus Healthcare, Regulatory and
Reimbursement Landscape - Republic of China
(Taiwan)

• The population of Taiwan increased slightly
  between 2008 and 2013 from 23.0 to 23.4 million,
  mainly due to rising life expectancy. However,
  the birth rate decreased at a negative Compound
  Annual Growth Rate (CAGR) of 0.04 between 2008
  and 2013. Government incentives such as those for
  new pharmaceutical companies establishing
  themselves in Taiwan, which include a reduction
  in income tax, will encourage foreign companies
  to invest. The countrys pharmaceutical market
  was estimated at 5.7 billion in 2013 and is
  projected to reach 8.2 billion by 2020 at a CAGR
  of 5.2. The medical device market was worth 2.2
  billion in 2013 and is projected to reach 3.1
  billion by 2020 at a CAGR of 5.0. These positive
  growth trends can primarily be attributed to - -
  An increasing elderly population- Universal
  health coverage- Government initiatives
• Buy a copy of this report by publisher name _at_
  http//www.reportsnreports.com/purchase.aspx?name
  287321 .

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
4
CountryFocus Healthcare, Regulatory and
Reimbursement Landscape - Republic of China
(Taiwan)

• ScopeThe report provides information on the
  healthcare, regulatory, and reimbursement
  landscape in Taiwan, and includes - - An
  overview of the pharmaceutical and medical device
  markets, comprising market size, segmentation,
  and key drivers and barriers- Profiles and SWOT
  analyses of the major players in the
  pharmaceutical market Pfizer, Sanofi-aventis,
  GlaxoSmithKline, Yung Shin Pharmaceutical and
  China Chemical Pharmaceutical- Insightful
  review of the reimbursement and regulatory
  landscape, with analysis covering details of the
  countrys healthcare reimbursement process,
  regulatory agencies and the approval processes
  for new drugs and medical devices
• Complete report is available _at_ http//www.reports
  nreports.com/reports/287321-countryfocus-healthcar
  e-regulatory-and-reimbursement-landscape-republic-
  of-china-taiwan-.html .

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
5
CountryFocus Healthcare, Regulatory and
Reimbursement Landscape - Republic of China
(Taiwan)

• Reasons to buyThis report will enhance your
  decision-making capability by allowing you to -
  - Develop business strategies by understanding
  the trends shaping and driving Taiwans
  healthcare market- Drive revenues by
  understanding the key trends, reimbursement and
  regulatory policies, pharmaceutical market
  segments, and companies likely to affect Taiwans
  healthcare market in the future- Formulate
  effective sales and marketing strategies by
  understanding the competitive landscape and
  analyzing the performance of various
  competitors- Organize your sales and marketing
  efforts by identifying the market categories and
  segments that present the best opportunities for
  consolidation, investment, and strategic
  partnership
• Inquire before Buying _at_ http//www.reportsnreports
  .com/contacts/inquirybeforebuy.aspx?name287321 .

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.
6
CountryFocus Healthcare, Regulatory and
Reimbursement Landscape - Republic of China
(Taiwan)

• SummaryResearcher, the industry analysis
  specialist, has released its latest report,
  CountryFocus Healthcare, Regulatory and
  Reimbursement Landscape - Republic of China
  (Taiwan). The report is an essential source of
  information and analysis on the healthcare,
  regulatory and reimbursement landscape in the
  Republic of China (Taiwan).
• It identifies the key trends in the countrys
  healthcare market and provides insights into its
  demographic, regulatory, and reimbursement
  landscape and healthcare infrastructure. Most
  importantly, the report provides valuable
  insights into the trends and segmentation of its
  pharmaceutical and medical device markets.
• It is built using data and information sourced
  from proprietary databases, secondary research,
  and in-house analysis by Researchers team of
  industry experts.
•  

Order this report by calling 1 888 391 5441 or
Send an email to sales_at_reportsandreports.com with
your contact details and questions if any.